Extended Release Drug Market

Drug delivery systems are engineered technologies for controlled release of drugs or to the targeted delivery of drugs. Drug delivery system is a kind of formulation that enables the administration of therapeutic agents in the body and improves its safety and efficacy by controlling the time, rate and place of drug release in the body. Most of the conventional oral products of drugs are formulated to release the active ingredient as soon as it is administered. Now the pattern has been changed to modified release dosage forms to achieve better therapeutic target.?Extended release drugs?is a type of dosage forms which allows a two-fold reduction in frequency of dosage administered in the body.
Extended Release Drug Market aims to provide a comprehensive presentation of the global market for Extended Release Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extended Release Drug. Extended Release Drug Market contains market size and forecasts of Extended Release Drug in global, including the following market information:
Global Extended Release Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Extended Release Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Sustained Release Drug Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Extended Release Drug include Pfizer, Mallinckrodt, Teva, Johnson & Johnson, Endo Pharmaceuticals, Purdue Pharma, Mylan, Hisamitsu Pharmaceutical and Sun Pharmaceutical Industries, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Extended Release Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Extended Release Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Extended Release Drug Market Segment Percentages, by Type, 2022 (%)
Sustained Release Drug
Controlled Release Drug
Global Extended Release Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Extended Release Drug Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Extended Release Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Extended Release Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Extended Release Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Extended Release Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Mallinckrodt
Teva
Johnson & Johnson
Endo Pharmaceuticals
Purdue Pharma
Mylan
Hisamitsu Pharmaceutical
Sun Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Extended Release Drug, market overview.
Chapter 2: Global Extended Release Drug market size in revenue.
Chapter 3: Detailed analysis of Extended Release Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Extended Release Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.